Información:
Error:
ID
34583
Descripción
Diabetes & Vardenafil; ODM derived from: https://clinicaltrials.gov/show/NCT02219646
Link
https://clinicaltrials.gov/show/NCT02219646
Palabras clave
Versiones (1)
- 19/1/19 19/1/19 -
Titular de derechos de autor
see on clinicaltrials.gov
Subido en
19 de enero de 2019
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Eligibility Type 2 Diabetes Mellitus (T2DM) NCT02219646
Eligibility Type 2 Diabetes Mellitus (T2DM) NCT02219646
- StudyEvent: Eligibility
Similar models
Eligibility Type 2 Diabetes Mellitus (T2DM) NCT02219646
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
ID.1
Item
male gender
boolean
ID.2
Item
signed written consent form
boolean
ID.3
Item
type 2 diabetes mellitus diagnosed within 5 years before enrolment in the study
boolean
ID.4
Item
body mass index (bmi) < 35
boolean
ID.5
Item
ed (severe, moderate or light according to the international index of erectile function - erectile function domain score < 26 (rosen et al. 1997))
boolean
ID.6
Item
age range: 40-65 years.
boolean
ID.7
Item
systemic diseases except type 2 diabetes mellitus
boolean
ID.8
Item
absence of ed
boolean
ID.9
Item
psychiatric disorders
boolean
ID.10
Item
all contraindications to treatment with pde5 inhibitors, such as retinitis pigmentosa, non-arteritic anterior ischaemic optic neuropathy, history of coronary artery disease, recent myocardial infarction, unstable angina, systemic arterial hypotension, nitric-oxide donors therapy, severe hepatic and renal failure.
boolean